Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacyStuart Prince(University of Turku), Maija Hollmén(University of Turku)TheranosticsJune 23, 202510.7150/thno.110544Cited by 8SaveCiteExport RISWatch citationsRelated PapersSystemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial|Clinical Cancer Research|2021|53